Literature DB >> 11565629

The placebo response in social phobia.

D B Oosterbaan1, A J van Balkom, P Spinhoven, R van Dyck.   

Abstract

The placebo response forms a growing problem in randomized, placebo-controlled clinical trials in psychiatry. Research into the placebo response is on the increase, but remains very limited in relation to social phobia. Together with the dropout rate, the placebo effect is an important factor limiting the discriminative properties of any study. In this study, we reviewed 15 placebo-controlled studies in social phobia, focussing on patients and study characteristics. In social phobia, the placebo effect has turned out to be moderately large and has shown no increase over the past decade. Placebo response was highest in large, multicentred trials and was independent of study duration. No validation for a placebo run-in was found. Taking into account both response to placebo and active drug, as well as dropout rate, the most discriminative results are probably to be expected in a sample of patients who are moderately to severely impaired. More research in the field of the placebo response is needed.

Entities:  

Mesh:

Year:  2001        PMID: 11565629     DOI: 10.1177/026988110101500314

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  3 in total

1.  Placebo treatment facilitates social trust and approach behavior.

Authors:  Xinyuan Yan; Xue Yong; Wenhao Huang; Yina Ma
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-14       Impact factor: 11.205

2.  Treatment of social anxiety with paroxetine: mediation of changes in anxiety and depression symptoms.

Authors:  Jared P Dempsey; Patrick K Randall; Suzanne E Thomas; Sarah W Book; Maureen H Carrigan
Journal:  Compr Psychiatry       Date:  2008-08-23       Impact factor: 3.735

3.  Open-label placebos reduce test anxiety and improve self-management skills: A randomized-controlled trial.

Authors:  Michael Schaefer; Claudia Denke; Rebecca Harke; Nina Olk; Merve Erkovan; Sören Enge
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.